Not available

General Information


DRACP ID  DRACP01177

Peptide Name   Not available

Sequence  IKWKAILDAVKKVL

Sequence Length  14

UniProt ID  Not available

PubChem CID  Not available

Origin  Not available

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
SK-OV-3 Ovarian serous cystadenocarcinoma Carcinoma it could confirm that the proliferation of the ovarian cancer cell was statistically carefully reduced in the culture medium containing the peptide of the concentration more than 25mM cultivated for 2 MTT assay 24 h Patent

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antitumor; Antimicrobial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP01177

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C79H137N19O17

Absent amino acids  CEFGHMNPQRSTY

Common amino acids  K

Mass  185716

Pl  10.8

Basic residues  4

Acidic residues  1

Hydrophobic residues  9

Net charge  3

Boman Index  279

Hydrophobicity  61.43

Aliphatic Index  167.14

Half Life 
  Mammalian: 2.8 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  5500

Absorbance 280nm  423.08

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID KR20160119943A

Patent Title  Peptide has antimicrobial antifungal and antitumor activity and uses thereof

Other Iinformation  Patent Application; Family: 2s / 2ex; Family Jurisdictions: KR; Legal Status: Active; Application No: 20150048678; Filed: Apr 6, 2015; Published: Oct 17, 2016; Earliest Priority: Apr 6, 2015; Granted: Dec 26, 2017

Other Published ID  KR101810630B1 




DRACP is developed by Dr.Zheng's team.